Juvenile Macular Degeneration Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: J5D741060E62EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Juvenile Macular Degeneration Treatment in Global, including the following market information:

Global Juvenile Macular Degeneration Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Juvenile Macular Degeneration Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Avacincaptad Pegol Sodium Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Juvenile Macular Degeneration Treatment include Acucela Inc., Alkeus Pharmaceuticals Inc, Astellas Pharma Inc, Copernicus Therapeutics Inc, Grupo Ferrer Internacional SA, Iris Pharma and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Juvenile Macular Degeneration Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Juvenile Macular Degeneration Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Juvenile Macular Degeneration Treatment Market Segment Percentages, by Type, 2021 (%)

• Avacincaptad Pegol Sodium
• Echothiophate Iodide
• Emixustat Hydrochloride
• FAB-111
• Others

Global Juvenile Macular Degeneration Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Juvenile Macular Degeneration Treatment Market Segment Percentages, by Application, 2021 (%)

• Clinic
• Hospital
• Homecare

Global Juvenile Macular Degeneration Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Juvenile Macular Degeneration Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Juvenile Macular Degeneration Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Juvenile Macular Degeneration Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Acucela Inc.
• Alkeus Pharmaceuticals Inc
• Astellas Pharma Inc
• Copernicus Therapeutics Inc
• Grupo Ferrer Internacional SA
• Iris Pharma
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Juvenile Macular Degeneration Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Juvenile Macular Degeneration Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL JUVENILE MACULAR DEGENERATION TREATMENT OVERALL MARKET SIZE

2.1 Global Juvenile Macular Degeneration Treatment Market Size: 2021 VS 2028
2.2 Global Juvenile Macular Degeneration Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Juvenile Macular Degeneration Treatment Players in Global Market
3.2 Top Global Juvenile Macular Degeneration Treatment Companies Ranked by Revenue
3.3 Global Juvenile Macular Degeneration Treatment Revenue by Companies
3.4 Top 3 and Top 5 Juvenile Macular Degeneration Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Juvenile Macular Degeneration Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Juvenile Macular Degeneration Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Juvenile Macular Degeneration Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Juvenile Macular Degeneration Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Juvenile Macular Degeneration Treatment Market Size Markets, 2021 & 2028
  4.1.2 Avacincaptad Pegol Sodium
  4.1.3 Echothiophate Iodide
  4.1.4 Emixustat Hydrochloride
  4.1.5 FAB-111
  4.1.6 Others
4.2 By Type - Global Juvenile Macular Degeneration Treatment Revenue & Forecasts
  4.2.1 By Type - Global Juvenile Macular Degeneration Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Juvenile Macular Degeneration Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Juvenile Macular Degeneration Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Juvenile Macular Degeneration Treatment Market Size, 2021 & 2028
  5.1.2 Clinic
  5.1.3 Hospital
  5.1.4 Homecare
5.2 By Application - Global Juvenile Macular Degeneration Treatment Revenue & Forecasts
  5.2.1 By Application - Global Juvenile Macular Degeneration Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Juvenile Macular Degeneration Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Juvenile Macular Degeneration Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Juvenile Macular Degeneration Treatment Market Size, 2021 & 2028
6.2 By Region - Global Juvenile Macular Degeneration Treatment Revenue & Forecasts
  6.2.1 By Region - Global Juvenile Macular Degeneration Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Juvenile Macular Degeneration Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Juvenile Macular Degeneration Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Juvenile Macular Degeneration Treatment Revenue, 2017-2028
  6.3.2 US Juvenile Macular Degeneration Treatment Market Size, 2017-2028
  6.3.3 Canada Juvenile Macular Degeneration Treatment Market Size, 2017-2028
  6.3.4 Mexico Juvenile Macular Degeneration Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Juvenile Macular Degeneration Treatment Revenue, 2017-2028
  6.4.2 Germany Juvenile Macular Degeneration Treatment Market Size, 2017-2028
  6.4.3 France Juvenile Macular Degeneration Treatment Market Size, 2017-2028
  6.4.4 U.K. Juvenile Macular Degeneration Treatment Market Size, 2017-2028
  6.4.5 Italy Juvenile Macular Degeneration Treatment Market Size, 2017-2028
  6.4.6 Russia Juvenile Macular Degeneration Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Juvenile Macular Degeneration Treatment Market Size, 2017-2028
  6.4.8 Benelux Juvenile Macular Degeneration Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Juvenile Macular Degeneration Treatment Revenue, 2017-2028
  6.5.2 China Juvenile Macular Degeneration Treatment Market Size, 2017-2028
  6.5.3 Japan Juvenile Macular Degeneration Treatment Market Size, 2017-2028
  6.5.4 South Korea Juvenile Macular Degeneration Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Juvenile Macular Degeneration Treatment Market Size, 2017-2028
  6.5.6 India Juvenile Macular Degeneration Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Juvenile Macular Degeneration Treatment Revenue, 2017-2028
  6.6.2 Brazil Juvenile Macular Degeneration Treatment Market Size, 2017-2028
  6.6.3 Argentina Juvenile Macular Degeneration Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Juvenile Macular Degeneration Treatment Revenue, 2017-2028
  6.7.2 Turkey Juvenile Macular Degeneration Treatment Market Size, 2017-2028
  6.7.3 Israel Juvenile Macular Degeneration Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Juvenile Macular Degeneration Treatment Market Size, 2017-2028
  6.7.5 UAE Juvenile Macular Degeneration Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Acucela Inc.
  7.1.1 Acucela Inc. Corporate Summary
  7.1.2 Acucela Inc. Business Overview
  7.1.3 Acucela Inc. Juvenile Macular Degeneration Treatment Major Product Offerings
  7.1.4 Acucela Inc. Juvenile Macular Degeneration Treatment Revenue in Global Market (2017-2022)
  7.1.5 Acucela Inc. Key News
7.2 Alkeus Pharmaceuticals Inc
  7.2.1 Alkeus Pharmaceuticals Inc Corporate Summary
  7.2.2 Alkeus Pharmaceuticals Inc Business Overview
  7.2.3 Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Major Product Offerings
  7.2.4 Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Revenue in Global Market (2017-2022)
  7.2.5 Alkeus Pharmaceuticals Inc Key News
7.3 Astellas Pharma Inc
  7.3.1 Astellas Pharma Inc Corporate Summary
  7.3.2 Astellas Pharma Inc Business Overview
  7.3.3 Astellas Pharma Inc Juvenile Macular Degeneration Treatment Major Product Offerings
  7.3.4 Astellas Pharma Inc Juvenile Macular Degeneration Treatment Revenue in Global Market (2017-2022)
  7.3.5 Astellas Pharma Inc Key News
7.4 Copernicus Therapeutics Inc
  7.4.1 Copernicus Therapeutics Inc Corporate Summary
  7.4.2 Copernicus Therapeutics Inc Business Overview
  7.4.3 Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Major Product Offerings
  7.4.4 Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Revenue in Global Market (2017-2022)
  7.4.5 Copernicus Therapeutics Inc Key News
7.5 Grupo Ferrer Internacional SA
  7.5.1 Grupo Ferrer Internacional SA Corporate Summary
  7.5.2 Grupo Ferrer Internacional SA Business Overview
  7.5.3 Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Major Product Offerings
  7.5.4 Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Revenue in Global Market (2017-2022)
  7.5.5 Grupo Ferrer Internacional SA Key News
7.6 Iris Pharma
  7.6.1 Iris Pharma Corporate Summary
  7.6.2 Iris Pharma Business Overview
  7.6.3 Iris Pharma Juvenile Macular Degeneration Treatment Major Product Offerings
  7.6.4 Iris Pharma Juvenile Macular Degeneration Treatment Revenue in Global Market (2017-2022)
  7.6.5 Iris Pharma Key News
7.7 Sanofi
  7.7.1 Sanofi Corporate Summary
  7.7.2 Sanofi Business Overview
  7.7.3 Sanofi Juvenile Macular Degeneration Treatment Major Product Offerings
  7.7.4 Sanofi Juvenile Macular Degeneration Treatment Revenue in Global Market (2017-2022)
  7.7.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Juvenile Macular Degeneration Treatment Market Opportunities & Trends in Global Market
Table 2. Juvenile Macular Degeneration Treatment Market Drivers in Global Market
Table 3. Juvenile Macular Degeneration Treatment Market Restraints in Global Market
Table 4. Key Players of Juvenile Macular Degeneration Treatment in Global Market
Table 5. Top Juvenile Macular Degeneration Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Juvenile Macular Degeneration Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Juvenile Macular Degeneration Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Juvenile Macular Degeneration Treatment Product Type
Table 9. List of Global Tier 1 Juvenile Macular Degeneration Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Juvenile Macular Degeneration Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Juvenile Macular Degeneration Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Juvenile Macular Degeneration Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Juvenile Macular Degeneration Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Juvenile Macular Degeneration Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Juvenile Macular Degeneration Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Juvenile Macular Degeneration Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Acucela Inc. Corporate Summary
Table 31. Acucela Inc. Juvenile Macular Degeneration Treatment Product Offerings
Table 32. Acucela Inc. Juvenile Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Alkeus Pharmaceuticals Inc Corporate Summary
Table 34. Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Product Offerings
Table 35. Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Astellas Pharma Inc Corporate Summary
Table 37. Astellas Pharma Inc Juvenile Macular Degeneration Treatment Product Offerings
Table 38. Astellas Pharma Inc Juvenile Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Copernicus Therapeutics Inc Corporate Summary
Table 40. Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Product Offerings
Table 41. Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Grupo Ferrer Internacional SA Corporate Summary
Table 43. Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Product Offerings
Table 44. Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Iris Pharma Corporate Summary
Table 46. Iris Pharma Juvenile Macular Degeneration Treatment Product Offerings
Table 47. Iris Pharma Juvenile Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Juvenile Macular Degeneration Treatment Product Offerings
Table 50. Sanofi Juvenile Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Juvenile Macular Degeneration Treatment Segment by Type in 2021
Figure 2. Juvenile Macular Degeneration Treatment Segment by Application in 2021
Figure 3. Global Juvenile Macular Degeneration Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Juvenile Macular Degeneration Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Juvenile Macular Degeneration Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Juvenile Macular Degeneration Treatment Revenue in 2021
Figure 8. By Type - Global Juvenile Macular Degeneration Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Juvenile Macular Degeneration Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Juvenile Macular Degeneration Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Juvenile Macular Degeneration Treatment Revenue Market Share, 2017-2028
Figure 12. US Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Juvenile Macular Degeneration Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Juvenile Macular Degeneration Treatment Revenue Market Share, 2017-2028
Figure 24. China Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Juvenile Macular Degeneration Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Juvenile Macular Degeneration Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Juvenile Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Acucela Inc. Juvenile Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Astellas Pharma Inc Juvenile Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Iris Pharma Juvenile Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi Juvenile Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)